<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38596549</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2000-9666</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Journal of community hospital internal medicine perspectives</Title><ISOAbbreviation>J Community Hosp Intern Med Perspect</ISOAbbreviation></Journal><ArticleTitle>Correlations of Long COVID Symptoms and Inflammatory Markers of Complete Blood Count (CBC): A Cross-sectional Study.</ArticleTitle><Pagination><StartPage>112</StartPage><EndPage>119</EndPage><MedlinePgn>112-119</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.55729/2000-9666.1259</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Long-COVID refers to lasting unspecific symptoms like fatigue, decreased concentration and sleep issues after infection which persist for at least three months and cannot be attributed to other causes. Previous studies surveyed the association between inflammatory markers like C - reactive protein (CRP) at hospital admission and long-COVID symptoms in the preceding months. Post-COVID syndrome can affect one-third of patients. Thus early diagnosis can assist in reducing burdens on public health. We attempted to see any correlations between complete blood count (CBC) markers (like red blood cell (RBC), white blood cell (WBC), Neutrophil to lymphocyte ratio (NLR), etc.) at hospital admission and long COVID symptoms at a 6-month follow-up.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">167 patients (44.9% females, mean age 49 years old) answered semi-structural interviews through telemedicine which focused on the three prominent symptoms: fatigue, loss of concentration and decreased libido. <i>Results</i>: Two third of patients have symptoms of long COVID and others do not have. NLR in the symptomatic group was statically higher. Patients who underwent decreased libido at a 6-month follow-up had significantly more severe lymphopenia (p = 0.028) and higher NLR values (p-value = 0.007). Poor mental concentration is associated with high WBC in numbers and polymorphonuclear (PMN) count. Other symptoms do not correlate with blood markers.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Utilizing available data like CBC can help predict the upcoming symptoms of previously hospitalized patients and further measures like rehabilitation. Additional investigations should be done on the effect of COVID vaccination on converting long COVID. Different variants of the virus may have different results.</AbstractText><CopyrightInformation>&#xa9; 2023 Greater Baltimore Medical Center.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Radkhah</LastName><ForeName>Hanieh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omidali</LastName><ForeName>Mehrnia</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hejrati</LastName><ForeName>Alireza</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahri</LastName><ForeName>Razman A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arefi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Behzadi</LastName><ForeName>Amirhossein</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eslami</LastName><ForeName>Mohamad</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khadembashiri</LastName><ForeName>Mohammadmehdi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khadembashiri</LastName><ForeName>Mohammadamin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Najafirashed</LastName><ForeName>Maryam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Science, Tehran, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amiri</LastName><ForeName>Bahareh S</ForeName><Initials>BS</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, School of Medicine, Hazrat-e Rasool General Hospital, Iran University of Medical Sciences, Tehran, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Community Hosp Intern Med Perspect</MedlineTA><NlmUniqueID>101601396</NlmUniqueID><ISSNLinking>2000-9666</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Complete blood count(CBC)</Keyword><Keyword MajorTopicYN="N">Decreased concentration</Keyword><Keyword MajorTopicYN="N">Decreased libido</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Inflammatory markers</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mean platelet volume(MPV)</Keyword><Keyword MajorTopicYN="N">Neutrophil to lymphocyte ratio(NLR)</Keyword><Keyword MajorTopicYN="N">Post-COVID-Syndrome</Keyword></KeywordList><CoiStatement>Conflict of interest: The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>10</Day><Hour>4</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38596549</ArticleId><ArticleId IdType="pmc">PMC11000855</ArticleId><ArticleId IdType="doi">10.55729/2000-9666.1259</ArticleId><ArticleId IdType="pii">jchim-13-06-112</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Asadi-Pooya AA, Nemati H, Shahisavandi M, et al. Long COVID in children and adolescents. World J Ped: WJP. 2021;17(5):495&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H, Raza S, Nowell J, Young M, Edison P. Long covid&#x2013;mechanisms, risk factors, and management. BMJ. 2021:374.</Citation><ArticleIdList><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jukema B, Smit K, Hopman M, et al. Neutrophil and eosinophil responses remain abnormal for several months in primary care patients with COVID-19 disease. Frontiers in allergy. 2022:3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9365032</ArticleId><ArticleId IdType="pubmed">35966226</ArticleId></ArticleIdList></Reference><Reference><Citation>Maamar M, Artime A, Pariente E, et al. Post-COVID-19 syndrome, inflammatory markers and sex differences. MedRxiv. 2021 Jul;8:2021&#x2013;07.</Citation></Reference><Reference><Citation>Thallapureddy K, Thallapureddy K, Zerda E, et al. Long-term complications of COVID-19 infection in adolescents and children. Current Ped Reports. 2022:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8803461</ArticleId><ArticleId IdType="pubmed">35127274</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabrera Martimbianco AL, Pacheco RL, Bagattini &#xc2; M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021;75(10):e14357.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8236920</ArticleId><ArticleId IdType="pubmed">33977626</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra N, Chowdhury M, Singh AK, et al. Clinical predictors of long COVID-19 and phenotypes of mild COVID-19 at a tertiary care centre in India. Drug Discov &amp; Ther. 2021;15(3):156&#x2013;161.</Citation><ArticleIdList><ArticleId IdType="pubmed">34234065</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A, Bozzani A, Tavazzi G, et al. Long COVID: long-term effects? Eur Heart J Suppl. 2021;23(Supplement_E):E1&#x2013;E5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020:370.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Karkhut S-M, Muzyka I, Savytska M, et al. Physiological predictors of long-term effects of COVID-19 in patients with SARS-CoV-2: focus on lymphocyte proliferation-improving micronutrients. Proceeding of the Shevchenko Scientific Society Medical Sciences; 2021;</Citation></Reference><Reference><Citation>van Kessel SA, Olde Hartman TC, Lucassen PL, van Jaarsveld CH. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M, Braillard O, Chappuis F, Guessous I. The chronification of post-COVID condition associated with neurocognitive symptoms, functional impairment and increased healthcare utilization. Sci Rep. 2022;12(1):14505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9403954</ArticleId><ArticleId IdType="pubmed">36008436</ArticleId></ArticleIdList></Reference><Reference><Citation>Chippa V, Aleem A, Anjum F. StatPearls. Treasure island (FL): StatPearls Publishing Copyright &#xa9; 2022, StatPearls Publishing LLC; 2022. Post acute coronavirus (COVID-19) syndrome.</Citation><ArticleIdList><ArticleId IdType="pubmed">34033370</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Venter C, Laubscher GJ, et al. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with Long COVID/Post-Acute Sequelae of COVID-19 (PASC) 2022</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Vlok M, Venter C, et al. Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021;20(1):1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Utrero-Rico A, Ruiz-Ruig&#xf3;mez M, Laguna-Goya R, et al. A short corticosteroid course reduces symptoms and immunological alterations underlying long-COVID. Biomedicines. 2021;9(11):1540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8614904</ArticleId><ArticleId IdType="pubmed">34829769</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelmaksoud MF. The role of laboratory markers as predictors of severity in Covid 19 patients. Minia J Med Research. 2022:367&#x2013;380.</Citation></Reference><Reference><Citation>Boehm BA, Packer CD. Persistent relapsing immune thrombocytopenia following COVID-19 infection. Cureus. 2022;14(7)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9392851</ArticleId><ArticleId IdType="pubmed">36004011</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gasalla M, Berman-Riu M, Pons J, et al. Hyper-inflammatory state and low T1 adaptive immune response in severe and critical acute COVID-19 patients. Front Med. 2022:9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9002349</ArticleId><ArticleId IdType="pubmed">35425776</ArticleId></ArticleIdList></Reference><Reference><Citation>Lionte C, Sorodoc V, Haliga RE, et al. Inflammatory and cardiac biomarkers in relation with post-acute COVID-19 and mortality: what we know after successive pandemic waves. Diagnostics. 2022;12(6):1373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9222082</ArticleId><ArticleId IdType="pubmed">35741183</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandori WJ, Padgett LE, Alimadadi A, et al. Single-cell immune profiling reveals long-term changes in myeloid cells and identifies a novel subset of CD9+ monocytes associated with COVID-19 hospitalization. J Leukoc Biol. 2022;112(5):1053&#x2013;1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9350203</ArticleId><ArticleId IdType="pubmed">35866369</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-G&#xf3;mez A, Vitall&#xe9; J, Gasca-Capote C, et al. Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection. Cell Mol Immunol. 2021;18(9):2128&#x2013;2139.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8294321</ArticleId><ArticleId IdType="pubmed">34290398</ArticleId></ArticleIdList></Reference><Reference><Citation>Siemi&#x144;ska I, W&#x119;glarczyk K, Surmiak M, et al. Mild and asymptomatic COVID-19 convalescents present long-term endotype of immunosuppression associated with neutrophil subsets possessing regulatory functions. Front Immunol. 2021:12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="pubmed">34659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Naughton A, et al. Longitudinal analysis of COVID-19 patients shows age-associated T cell changes independent of ongoing ill-health. Front Immunol. 2021:1593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8138306</ArticleId><ArticleId IdType="pubmed">34025675</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortellini A, Gennari A, Pommeret F, et al. COVID-19 sequelae and the host proinflammatory response: an analysis from the OnCovid registry. J Natl Cancer Inst. 2022;114(7):979&#x2013;987.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047221</ArticleId><ArticleId IdType="pubmed">35417006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanini S, Montaldo C, Nicastri E, et al. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: a longitudinal descriptive cohort study. PLoS One. 2020;15(12):e0244129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769441</ArticleId><ArticleId IdType="pubmed">33370366</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao J, Dai R, Du RC, Zhu Y, Shui LP, Luo XH. Hematologic changes predict clinical outcome in recovered patients with COVID-19. Ann Hematol. 2021;100(3):675&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848253</ArticleId><ArticleId IdType="pubmed">33523290</ArticleId></ArticleIdList></Reference><Reference><Citation>Baimukhamedov C. How long is long COVID. Wiley Online Library. 2022</Citation></Reference><Reference><Citation>Ghosh P, Niesen MJ, Pawlowski C, et al. Severe acute infection and chronic pulmonary disease are risk factors for developing post-COVID-19 conditions. medRxiv. 2022</Citation></Reference><Reference><Citation>Pilotto A, Cristillo V, Cotti Piccinelli S, et al. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci. 2021;42(12):4903&#x2013;4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;28(8):1706&#x2013;1714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde MW, Billig Rose E, Lindsell CJ, et al. Characteristics of adult outpatients and inpatients with COVID-19 - 11 academic medical centers, United States, march-may 2020. MMWR Morbidity and mortality weekly report. 2020;69(26):841&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7332092</ArticleId><ArticleId IdType="pubmed">32614810</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, et al. Sequelae in adults at 6 Months after COVID-19 infection. JAMA Netw Open. 2021;4(2):e210830.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry B, Cheruiyot I, Vikse J, et al. Lymphopenia and neutrophilia at admission predicts severity and mortality in patients with COVID-19: a meta-analysis. Acta Biomed: Atenei Parmensis. 2020;91(3):e2020008.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716963</ArticleId><ArticleId IdType="pubmed">32921706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fathi N, Rezaei N. Lymphopenia in COVID-19: therapeutic opportunities. Cell Biol Int. 2020;44(9):1792&#x2013;1797.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283672</ArticleId><ArticleId IdType="pubmed">32458561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun T, Guo L, Tian F, et al. Rehabilitation of patients with COVID-19. Expet Rev Respir Med. 2020;14(12):1249&#x2013;1256.</Citation><ArticleIdList><ArticleId IdType="pubmed">32799694</ArticleId></ArticleIdList></Reference><Reference><Citation>Could cognitive behavioural therapy be an effective treatment for long COVID and post COVID-19 fatigue syndrome? Vink M, Vink-Niese A, editors. Lessons from the Qure study for Q-fever fatigue syndrome Healthcare. 2020 MDPI.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7764131</ArticleId><ArticleId IdType="pubmed">33322316</ArticleId></ArticleIdList></Reference><Reference><Citation>Myall KJ, Mukherjee B, Castanheira AM, et al. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Annals American Thoracic Society. 2021;18(5):799&#x2013;806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086530</ArticleId><ArticleId IdType="pubmed">33433263</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya JM, Rojas M, Salinas ML, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20(11):102947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Orr&#xf9; G, Bertelloni D, Diolaiuti F, et al. Long-COVID syndrome? A study on the persistence of neurological, psychological and physiological symptoms. Healthcare (Basel Switzerland) 2021;9(5)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8152255</ArticleId><ArticleId IdType="pubmed">34068009</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A, Bozzani A, Tavazzi G, et al. Long COVID: long-term effects? European heart journal supplements. J European Society of Cardiology. 2021;23(Suppl E):E1&#x2013;E5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Azcue N, G&#xf3;mez-Esteban JC, Acera M, et al. Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder? J Transl Med. 2022;20(1):569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9724286</ArticleId><ArticleId IdType="pubmed">36474290</ArticleId></ArticleIdList></Reference><Reference><Citation>Henneghan AM, Lewis KA, Gill E, Kesler SR. Cognitive impairment in non-critical, mild-to-moderate COVID-19 survivors. Front Psychol. 2022;13:770459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8891805</ArticleId><ArticleId IdType="pubmed">35250714</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajoulvand R, Hashemi S, Askari E, Mohammadi R, Behzadifar M, Imani-Nasab MH. Post-pandemic stress of COVID-19 among high-risk groups: a systematic review and meta-analysis. J Affect Disord. 2022;319:638&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9512530</ArticleId><ArticleId IdType="pubmed">36174783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, Poletti S, Benedetti F. Post-COVID-19 depressive symptoms: epidemiology, pathophysiology, and pharmacological treatment. CNS Drugs. 2022;36(7):681&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210800</ArticleId><ArticleId IdType="pubmed">35727534</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed GK, Khedr EM, Hamad DA, Meshref TS, Hashem MM, Aly MM. Long term impact of Covid-19 infection on sleep and mental health: a cross-sectional study. Psychiatr Res. 2021;305:114243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8507572</ArticleId><ArticleId IdType="pubmed">34673325</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Condoy JS, Fernandez-Naranjo R, Vasconez-Gonz&#xe1;lez E, et al. Long COVID at different altitudes: a countrywide epidemiological analysis. Int J Environ Res Publ Health. 2022;19(22)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9690364</ArticleId><ArticleId IdType="pubmed">36429392</ArticleId></ArticleIdList></Reference><Reference><Citation>Nawaz MU, Rivera E, Vinayak S, et al. Comparison of sexual function before and after COVID-19 infection in female patients. Cureus. 2021;13(9):e18156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8525675</ArticleId><ArticleId IdType="pubmed">34692350</ArticleId></ArticleIdList></Reference><Reference><Citation>Szuster E, Kostrzewska P, Pawlikowska A, Mandera A, Biernikiewicz M, Ka&#x142;ka D. Mental and sexual health of polish women of reproductive age during the COVID-19 pandemic - an online survey. Sex Med. 2021;9(4):100367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8360924</ArticleId><ArticleId IdType="pubmed">34146832</ArticleId></ArticleIdList></Reference><Reference><Citation>Szuster E, Kostrzewska P, Pawlikowska A, et al. Depressive and sexual disorders during the first and second wave of the COVID-19 pandemic among young polish women. Int J Environ Res Publ Health. 2022;19(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8835018</ArticleId><ArticleId IdType="pubmed">35162908</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilotto A, Cristillo V, Cotti Piccinelli S, et al. Long-term neurological manifestations of COVID-19: prevalence and predictive factors. Neurol Sci: Official J Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 2021;42(12):4903&#x2013;4907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8439956</ArticleId><ArticleId IdType="pubmed">34523082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya Y, Kaya C, Tahta T, Kartal T, Tokg&#xf6;z VY. Examination of the effect of COVID-19 on sexual dysfunction in women. Int J Clin Pract. 2021;75(3):e13923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7883257</ArticleId><ArticleId IdType="pubmed">33300261</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, Crespo M, Poveda E. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. 2022;12(1):3369.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet (London, England) 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. 2021;27(9):895&#x2013;906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>
Van Herck MGY, Houben-Wilke S, Machado F, et al. 
Groups. 






SFiLCW-BQF-uSiMoOLCS. 2021;23(9):e30274. JMIR  https://www.jmir.org/2021/9/e30274U,10.2196/30274D.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8457337</ArticleId><ArticleId IdType="pubmed">34494964</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>